Leadership Team

Nicholas Nicolaides, Ph.D.

Nicholas Nicolaides, Ph.D.

President, Chief Executive Officer

Nicholas C. Nicolaides Ph.D. is a co-founder of Morphotek. Dr. Nicolaides co-invented morphogenics, a whole genome evolution technology that became the basis of Morphotek. He is an Ernst & Young Entrepreneur of the Year Award® winner (2007) for his innovations and contributions to the life science industry in the Greater Philadelphia Region.

Prior to joining Morphotek, Dr. Nicolaides was Director of Research at the Magainin Institute of Molecular Medicine, a division of Magainin Pharmaceuticals, Inc. Dr. Nicolaides' scientific background is in human molecular genetics, where he has studied and authored many scientific papers on the molecular and genetic basis of cancer and respiratory disease. He currently serves as an advisor on several institutional boards.

Dr. Nicolaides received his Ph.D. in genetics at Thomas Jefferson University, Philadelphia, PA and continued his post-doctoral training at Johns Hopkins University, Baltimore, MD.


Rodney Dausch

Rodney Dausch

Chief Financial Officer and Vice President of Operations

Rodney Dausch has over 30 years of experience in financial and operations management, most recently as Executive Vice President and Chief Operating Officer for a publicly held biopharmaceutical company. While there, he also led its successful initial and follow-on public offerings in the role of Chief Financial Officer.

Prior to moving into the biotechnology sector, Mr. Dausch began his career with Ernst & Young. He received his B.S. from Loyola College and was formerly a Certified Public Accountant.


Luigi Grasso, Ph.D

Luigi Grasso, Ph.D.

Senior Vice President of Research and Development, Chief Scientific Officer

Luigi Grasso, Ph.D. is a co-founder of Morphotek. Prior to joining the company, he was Assistant Director of Research at the Magainin Institute of Molecular Medicine, a division of Magainin Pharmaceuticals, Inc.

Dr. Grasso's scientific background is in pathology and molecular genetics, where he has studied and co-authored many scientific papers on the molecular and genetic basis of human disease.

Dr. Grasso received his Ph.D. in Pathology at the University of Catania, Italy and continued his post-doctoral training at the Kimmel Cancer Center and Thomas Jefferson University in Philadelphia, PA.